Dr. Scholz uses advanced genetics to understand neurodegenerative disorders
The American Neurological Association (ANA) has announced that Sonja W. Scholz, M.D., Ph.D., an investigator at the National Institutes of Health is this year’s winner of the Soriano Lectureship. Established in 1987, the Soriano Lectureship is awarded every year for a “brilliant lecture delivered by an outstanding scientist” at the ANA’s annual meetings. Dr. Scholz won the award for her presentation, entitled “Genomic Approaches Paving the Way for Precision Neurology,” which she will give on October 5th, 2020. The award includes a commemorative plaque and a $1,000 honorarium.
Dr. Scholz leads a team of researchers in the Division of Intramural Research at the NIH’s National Institute of Neurological Disorders and Stroke. They use advanced genetic techniques to study neurodegenerative disorders, including dementia with Lewy bodies, multiple system atrophy, and frontotemporal dementia. During the presentation, Dr. Scholz “will outline how genetics will likely impact daily clinical practice” involved in treating these types of disorders.
Dr. Scholz received her M.D., from the Medical University Innsbruck, Austria and a Ph.D. in Neurogenomics from University College London, UK. She has worked as a post-doctoral fellow at the NIH’s National Institute of Aging and as a resident at Johns Hopkins University School of Medicine in Baltimore, M.D. In 2015, Dr. Scholz joined the NIH via a McFarland Transition to Independence Award for Neurologist-Scientists. Currently, her lab is supported by a Lasker Clinical Research Tenure Track Investigator designation within the NINDS Neurogenetics Branch.
For more information:
NINDS is the nation’s leading funder of research on the brain and nervous system. The mission of NINDS is to seek fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.